Page 93 - Micron News Today

Omicron subvariants of SARS-CoV-2 -; the virus behind COVID-19 -; have shown an uncanny knack for evading antibodies produced either by vaccines or exposure to earlier versions of the virus, leading to many breakthrough infections.

The Australian winter will likely see a rise in COVID cases again. The cycle of subvariants will leave us exposed and hasten the waning of immunity, writes Catherine Bennett.

Taiwan-based DRAM chipmaker Nanya Technology said the company is still under pressure to limit output growth amid oversupply in the memory industry.

Researchers assessed the incidence rate of SARS-CoV-2 infections pre- and post-SARS-CoV-2 Omicron VOC dominance among infants.

The Indian Council of Medical Research (ICMR) has isolated the omicron subvariant and assessed the vaccine efficiency. It has found that the virus is not as lethal as it was earlier

Reported the identification of a panel of vaccinee-derived antibodies with broad-spectrum neutralization activity.

The industry is playing a key role in siting and developing new semiconductors and similar plants.

Researchers found antibodies that neutralize all current SARS-CoV-2 variants.

Long Covid patients are likely to suffer from persistent psychiatric symptoms, like anxiety and depression, according to a study. Learn more here.

The Cyberspace Administration of China on March 31 said it launched an investigation into Microns products in China on the grounds of "safeguarding supply chain security of critical information infrastructure," a move viewed as Beijings retaliation against Washingtons technological and strategic curb on Chinas development.